Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Balavarca, Y; Pearce, K; Norden, J; Collin, M; Jackson, G; Holler, E; Dressel, R; Kolb, HJ; Greinix, H; Socie, G; Toubert, A; Rocha, V; Gluckman, E; Hromadnikova, I; Sedlacek, P; Wolff, D; Holtick, U; Dickinson, A; Bickeböller, H.
Predicting survival using clinical risk scores and non-HLA immunogenetics.
Bone Marrow Transplant. 2015; 50(11):1445-1452 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Greinix Hildegard

Dimensions Citations:

Plum Analytics:
Previous studies of non-histocompatibility leukocyte antigen (HLA) gene single-nucleotide polymorphisms (SNPs) on subgroups of patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) revealed an association with transplant outcome. This study further evaluated the association of non-HLA polymorphisms with overall survival in a cohort of 762 HSCT patients using data on 26 polymorphisms in 16 non-HLA genes. When viewed in addition to an already established clinical risk score (EBMT-score), three polymorphisms: rs8177374 in the gene for MyD88-adapter-like (MAL; P=0.026), rs9340799 in the oestrogen receptor gene (ESR; P=0.003) and rs1800795 in interleukin-6 (IL-6; P=0.007) were found to be associated with reduced overall survival, whereas the haplo-genotype (ACC/ACC) in IL-10 was protective (P=0.02). The addition of these non-HLA polymorphisms in a Cox regression model alongside the EBMT-score improved discrimination between risk groups and increased the level of prediction compared with the EBMT-score alone (gain in prediction capability for EBMT-genetic-score 10.8%). Results also demonstrated how changes in clinical practice through time have altered the effects of non-HLA analysis. The study illustrates the significance of non-HLA genotyping prior to HSCT and the importance of further investigation into non-HLA gene polymorphisms in risk prediction.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Aged -
Allografts -
Cause of Death -
Child -
Estrogen Receptor alpha - genetics
Female -
Follow-Up Studies -
Genotype -
Graft vs Host Disease - mortality
Haplotypes -
Hematologic Neoplasms - mortality
Hematologic Neoplasms - therapy
Hematopoietic Stem Cell Transplantation - mortality
Histocompatibility -
Humans -
Infection - mortality
Interleukin-10 - genetics
Interleukin-6 - genetics
Kaplan-Meier Estimate -
Male -
Membrane Glycoproteins - genetics
Middle Aged -
Multiple Organ Failure - mortality
Polymorphism, Single Nucleotide -
Prognosis -
Proportional Hazards Models -
Receptors, Interleukin-1 - genetics
Risk Assessment - methods
Transplantation Conditioning - adverse effects
Treatment Outcome -

© Meduni Graz Impressum